Efficacy profile of a bivalent Staphylococcus aureus glycoconjugated vaccine in adults on hemodialysis: Phase III randomized study.
Hum Vaccin Immunother
; 11(3): 632-41, 2015.
Article
em En
| MEDLINE
| ID: mdl-25483694
Palavras-chave
CI, confidence interval; ClfA, S. aureus clumping factor A; ELISA, enzyme-linked immunosorbent assay; ESRD, end-stage renal disease; GMC, geometric mean concentration; OPK, opsonophagocytic killing; SAE, Serious adverse event; Staphylococcus aureus; T5/T8, Staphylococcus aureus type 5 and 8 capsular polysaccharides; VE, vaccine efficacy; end stage renal disease; hemodialysis; immunogenicity; vaccine; vaccine safety
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções Estafilocócicas
/
Staphylococcus aureus
/
Vacinas Antiestafilocócicas
/
Diálise Renal
/
Bacteriemia
Tipo de estudo:
Clinical_trials
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article